1 The e ects of acharan sulphate, a glycosaminoglycan isolated from the giant African snail Achatina fulica, on angiogenesis in the granulation tissue were analysed using an air pouch-type carrageenin-induced in¯ammation model in rats and a cotton thread-induced in¯ammation model in mice. 2 In the carrageenin-induced in¯ammation model in rats, intra-pouch injections of acharan sulphate (5 and 50 mg) inhibited the pouch¯uid accumulation and the granulation tissue formation as well as the angiogenesis in the granulation tissue at day 6 in a dose-dependent manner. 3 The inhibitory e ects of acharan sulphate at 50 mg on the pouch¯uid accumulation and the leucocyte in®ltration into the pouch¯uid was not so e ective as that of the cyclo-oxygenase inhibitor indomethacin at 100 mg, but the inhibitory e ects of acharan sulphate at 50 mg on the granulation tissue formation and angiogenesis in the granulation tissue were almost the same as those of indomethacin at 100 mg. 4 Acharan sulphate did not a ect levels of vascular endothelial growth factor (VEGF) in the granulation tissue and in the pouch¯uid at day 6, but indomethacin signi®cantly lowered them. 5 In the cotton thread-induced in¯ammation model in mice, injections of acharan sulphate (10 mg) at the site of the cotton thread implantation inhibited the granulation tissue formation and angiogenesis as indomethacin (20 mg) did. Acharan sulphate (10 mg) did not a ect levels of VEGF in the cotton thread-induced granulation tissue at day 5, but indomethacin (20 mg) signi®cantly lowered them. 6 In culture of human vascular endothelial cells, acharan sulphate at 10 and 100 mg ml 71 inhibited VEGF-induced capillary tube formation. 7 These ®ndings suggest that the inhibitory e ect of acharan sulphate on angiogenesis in carrageenin-and cotton thread-induced granulation tissues is not due to the inhibition of VEGF protein induction, but is due to the inhibition of VEGF-induced vascular tube formation.